BIOMAT Database Logo BIOMAT Database Logo

[Clinical characteristics of patients with hypertension resistant to antihypertensive drug therapy]. 1996

J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Kliniki Nadciśnienia Tetniczego Instytutu Kardiologii AM w Poznaniu.

Two groups of hypertensive patients: 137 responsive (on one or two drugs) and 162 resistant on antihypertensive treatment in the similar age were compared. Resistant patients (on three or more drugs) characterize by significantly higher body weight and BMI, longer history of hypertension, more frequent hypertension prevalance in family members and lower education. Level of triglycerides in resistant on antihypertensive treatment patients was significantly higher than in responsive patients. Insulin level in blood in 31 patients with essential hypertension was significantly higher than in 36 healthy persons and 20 patients with renovascular hypertension and resistant on antihypertensive therapy. In 14 patients with essential hypertension resistant to treatment insulin level one hour after oral glucose load was significantly (p < 0.01) higher than in 16 patients with essential hypertension responsive to antihypertensive treatment.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive

Related Publications

J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Characteristics of patients resistant to antihypertensive drug therapy.
May 1991, Journal of internal medicine,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension study.
November 2019, Journal of hypertension,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Assessment of drug compliance in patients with high blood pressure resistant to antihypertensive therapy.
May 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
[Clinical characteristics and antihypertensive therapy in hypertension in the elderly].
March 2007, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Psychological characteristics and responses to antihypertensive drug therapy.
January 2002, Journal of clinical hypertension (Greenwich, Conn.),
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Baroreflex activation therapy for patients with drug-resistant hypertension.
August 2014, Expert review of cardiovascular therapy,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Identifying poor adherence to antihypertensive medications in patients with resistant hypertension.
January 2019, British journal of clinical pharmacology,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension.
March 2016, Hypertension (Dallas, Tex. : 1979),
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension?
September 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
J Głuszek, and B Raszeja-Wanic, and I Stachowiak, and F Banaszak, and L Szcześniak, and D Musialik, and T Kosicka, and A Tykarski, and A Boruczkowska, and A Skołuda, and A Małaczyńska, and A Wichrowska, and K Rutz-Danielczak, and B Krasińska
Adherence to antihypertensive drug treatment in patients with apparently treatment-resistant hypertension in the INSPiRED pilot study.
June 2019, Blood pressure,
Copied contents to your clipboard!